For Physicians
Company
Support
Sign in
Register
Home
Medical Oncology
Question
Would you offer gemcitabine/cisplatin (or other platinum-based regimens) for metastatic pancreatic cancer harboring somatic ATM mutations?
3
1 Answers
Add Answer
Mednet Member
Medical Oncology · St. Vincent's Medical Center
Yes, potential sensitivity to DNA-damaging agents.
Register
or
Sign In
to see full answer
Would you offer gemcitabine/cisplatin (or other platinum-based regimens) for metastatic pancreatic cancer harboring somatic ATM mutations? | Mednet
